Keyphrases
Serine Protease Inhibitor
100%
Breast Cancer
100%
Ovarian Cancer
100%
Metastasis
100%
Prostate Cancer
100%
Mesotrypsin
75%
Kallikrein 6
75%
Bioreactor
25%
Tumor
25%
Therapeutic Efficacy
25%
Protease
25%
High Affinity
25%
Cancer Metastasis
25%
Therapeutic Intervention
25%
Long Retention Time
25%
Potential Therapeutics
25%
Safety Profile
25%
Increased Activity
25%
New Agents
25%
Cancer Invasion
25%
Novel Therapies
25%
Primary Tumor
25%
Targeted Therapy
25%
Pharmacokinetic Properties
25%
Putative Targets
25%
Good Safety
25%
Metastatic Breast Cancer
25%
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
25%
Metastatic Process
25%
Manufacturability
25%
Kunitz Trypsin Inhibitor
25%
Amyloid Protein Precursor
25%
Anti-metastatic Activity
25%
Metastatic Ovarian Cancer
25%
Medicine and Dentistry
Serine Proteinase Inhibitor
100%
Breast Cancer
100%
Prostate Cancer
100%
Ovarian Cancer
100%
Metastatic Carcinoma
100%
Kallikrein 6
60%
In Vitro
20%
Neoplasm
20%
Combination Therapy
20%
Proteinase Inhibitor
20%
Proteinase
20%
Pharmacokinetics
20%
Primary Tumor
20%
Targeted Therapy
20%
Tumor Invasion
20%
Amyloid Precursor Protein
20%
Metastasis Inhibition
20%
Pharmacology, Toxicology and Pharmaceutical Science
Serine Proteinase Inhibitor
100%
Breast Cancer
100%
Prostate Cancer
100%
Ovary Cancer
100%
Kallikrein 6
60%
Neoplasm
20%
Combination Therapy
20%
Proteinase Inhibitor
20%
Proteinase
20%
Pharmacokinetics
20%
Metastasis
20%
Primary Tumor
20%
Tumor Invasion
20%
Amyloid Precursor Protein
20%
Metastasis Inhibition
20%